Cargando…

Effectiveness of Concomitant Chemoradiotherapy with Gemcitabine in Locally Advanced Cervical Cancer Patients with Comorbidities

PURPOSE: The standard treatment for locally advanced cervical cancer (LACC) is concomitant chemoradiotherapy with cisplatin (CDDP) followed by brachytherapy. The presence of comorbidities are risk factors for nephrotoxicity and are associated with lower survival. Gemcitabine is a radiosensitizing dr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brau-Figueroa, Hasan, Arango-Bravo, Eder, Castro-Eguiluz, Denisse, Galicia-Carmona, Tatiana, Lugo-Alferez, Leopoldo Abraham, Cruz-Bautista, Ivette, Jiménez-Lima, Roberto, Cetina-Pérez, Lucely
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016315/ https://www.ncbi.nlm.nih.gov/pubmed/34384015 http://dx.doi.org/10.4143/crt.2021.375

Ejemplares similares

The health system and access to treatment in patients with cervical cancer in Mexico
por: Arango-Bravo, Eder A., et al.
Publicado: (2022)

Cervical cancer prevention program in Mexico disrupted due to COVID-19 pandemic: Challenges and opportunities
por: Cruz-Valdez, Aurelio, et al.
Publicado: (2023)

Impact of metabolic syndrome on the risk of endometrial cancer and the role of lifestyle in prevention
por: Pérez-Martín, Alejandra Rocío, et al.
Publicado: (2022)

Epithelial–mesenchymal transition, proliferation, and angiogenesis in locally advanced cervical cancer treated with chemoradiotherapy
por: Rojas‐Puentes, Leonardo, et al.
Publicado: (2016)

Mismatch repair protein expression and intratumoral budding in rectal cancer are associated with an increased pathological complete response to preoperative chemoradiotherapy: A case-control study
por: Lino-Silva, Leonardo S, et al.
Publicado: (2018)

Clinical Benefits of Olaparib in Mexican Ovarian Cancer Patients With Founder Mutation BRCA1-Del ex9-12
por: Gallardo-Rincón, Dolores, et al.
Publicado: (2022)

Phase II Trial of Postoperative Adjuvant Gemcitabine and Cisplatin Chemotherapy Followed by Chemoradiotherapy with Gemcitabine in Patients with Resected Pancreatic Cancer
por: Lee, Kyung-Hun, et al.
Publicado: (2021)

Comparison of vinorelbine with cisplatin in concomitant chemoradiotherapy in head and neck carcinoma
por: Devleena,, et al.
Publicado: (2010)

Radiosensitizers in cervical cancer. Cisplatin and beyond
por: Candelaria, Myrna, et al.
Publicado: (2006)

New molecular targets against cervical cancer
por: Duenas-Gonzalez, Alfonso, et al.
Publicado: (2014)

Regarding the study testing the addition of gemcitabine to concurrent chemoradiotherapy in cervical carcinoma: Clarity needed
por: Revannasiddaiah, Swaroop, et al.
Publicado: (2013)

Gemcitabine-Based Chemoradiotherapy Enhanced by a PARP Inhibitor in Pancreatic Cancer Cell Lines
por: Waissi, Waisse, et al.
Publicado: (2021)

Chemoradiotherapy with concurrent gemcitabine and cisplatin with or without sequential chemotherapy with gemcitabine/cisplatin vs chemoradiotherapy with concurrent 5-fluorouracil in patients with locally advanced pancreatic cancer – a multi-centre randomised phase II study
por: Wilkowski, R, et al.
Publicado: (2009)

Progressive resistance training in head and neck cancer patients undergoing concomitant chemoradiotherapy
por: Lonkvist, Camilla K., et al.
Publicado: (2017)

Concomitant-chemoradiotherapy-associated oral lesions in patients with oral squamous-cell carcinoma
por: Minhas, Sadia, et al.
Publicado: (2017)

Epigenetics of cervical cancer. An overview and therapeutic perspectives
por: Dueñas-González, Alfonso, et al.
Publicado: (2005)

Circulating biomarkers and outcomes from a randomised phase 2 trial of gemcitabine versus capecitabine-based chemoradiotherapy for pancreatic cancer
por: Willenbrock, Frances, et al.
Publicado: (2020)

Concurrent chemoradiotherapy with low dose weekly gemcitabine in stage III non-small cell lung cancer
por: Abacioglu, Ufuk, et al.
Publicado: (2005)

Concurrent chemoradiotherapy using gemcitabine and nedaplatin in recurrent or locally advanced head and neck squamous cell carcinoma
por: Huo, Rui-Xue, et al.
Publicado: (2022)

Serous adenocarcinoma of the fallopian tube, associated with verrocous carcinoma of the uterine cervix: a case report of synchronic rare gynecological tumors
por: Cantu de Leon, David, et al.
Publicado: (2009)

El microcrédito como herramienta contra la pobreza
por: Galicia Alonso, Denisse
Publicado: (2008)

Neoadjuvant chemotherapy with gemcitabine and cisplatin followed by selective bladder preservation chemoradiotherapy in muscle-invasive urothelial carcinoma of bladder
por: Sung, Hyun Hwan, et al.
Publicado: (2022)

Neoadjuvant concurrent chemoradiotherapy using infusional gemcitabine in locally advanced rectal cancer: A phase II trial
por: Bazarbashi, Shouki, et al.
Publicado: (2022)

Concomitant inpatient prescribing of strong opioids with sedatives: Associations with comorbid conditions
por: Li, Ray J., et al.
Publicado: (2021)

Vulvar fibroadenoma: a common neoplasm in an uncommon site
por: Cantú de Leon, David, et al.
Publicado: (2009)

Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
por: Zeng, Zhen, et al.
Publicado: (2018)

The Survival Benefit of Chemoradiotherapy following Induction Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Unresectable Locally Advanced Pancreatic Cancer
por: Takada, Ryoji, et al.
Publicado: (2021)

Concomitant Statin Use Has a Favorable Effect on Gemcitabine-Erlotinib Combination Chemotherapy for Advanced Pancreatic Cancer
por: Moon, Do Chang, et al.
Publicado: (2016)

Concomitant intensive chemoradiotherapy induction in non-metastatic inflammatory breast cancer: long-term follow-up
por: Genet, D, et al.
Publicado: (2007)

A single centre experience with sequential and concomitant chemoradiotherapy in locally advanced stage IV tonsillar cancer
por: D Prestwich, Robin J, et al.
Publicado: (2010)

Correlation between hematological parameters and outcome in patients with locally advanced cervical cancer treated by concomitant chemoradiotherapy
por: Gennigens, Christine, et al.
Publicado: (2020)

Survival benefits from concomitant chemoradiotherapy before radical surgery in stage IVA sinonasal mucosal melanoma?
por: Hafström, Anna, et al.
Publicado: (2019)

Primary Malignant Melanoma of the Uterine Cervix Treated with Ultraradical Surgery: A Case Report
por: Calderón-Salazar, Luz, et al.
Publicado: (2011)

Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial
por: Mukherjee, Somnath, et al.
Publicado: (2013)

Serum nucleosomes during neoadjuvant chemotherapy in patients with cervical cancer. Predictive and prognostic significance
por: Trejo-Becerril, Catalina, et al.
Publicado: (2005)

Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients: A single-center analysis
por: Roh, Tae Hoon, et al.
Publicado: (2017)

Total neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy and adjuvant gemcitabine for resectable and borderline resectable pancreatic cancer (PREOPANC-2 trial): study protocol for a nationwide multicenter randomized controlled trial
por: Janssen, Q. P., et al.
Publicado: (2021)

Comorbidity in limited disease small-cell lung cancer: Age-adjusted Charlson comorbidity index and its association with overall survival following chemoradiotherapy
por: Fink, Christoph A., et al.
Publicado: (2023)

Radiation-sparing managements for cervical cancer: a developing countries perspective
por: Candelaria, Myrna, et al.
Publicado: (2006)

Gemcitabine/cisplatin versus 5-fluorouracil/mitomycin C chemoradiotherapy in locally advanced pancreatic cancer: a retrospective analysis of 93 patients
por: Brunner, Thomas B, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_b6tjohlaj9ep90j23qc6trvjca